

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | modulation by symbiont of host defense response (GO:0052031) | 6.91034710 |
| 2 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 6.91034710 |
| 3 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 6.91034710 |
| 4 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 6.91034710 |
| 5 | modulation by symbiont of host immune response (GO:0052553) | 6.91034710 |
| 6 | positive regulation by symbiont of host defense response (GO:0052509) | 6.91034710 |
| 7 | regulation of interferon-beta biosynthetic process (GO:0045357) | 5.46217457 |
| 8 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.38634011 |
| 9 | positive regulation of interferon-alpha production (GO:0032727) | 5.34312214 |
| 10 | neutrophil activation involved in immune response (GO:0002283) | 5.30994576 |
| 11 | regulation of interferon-alpha production (GO:0032647) | 5.07090062 |
| 12 | negative regulation of interleukin-12 production (GO:0032695) | 4.88711868 |
| 13 | macrophage activation involved in immune response (GO:0002281) | 4.78421157 |
| 14 | response to peptidoglycan (GO:0032494) | 4.64976412 |
| 15 | immunoglobulin mediated immune response (GO:0016064) | 4.64168684 |
| 16 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.56875474 |
| 17 | response to host immune response (GO:0052572) | 4.56875474 |
| 18 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 4.35719124 |
| 19 | regulation of vitamin D biosynthetic process (GO:0060556) | 4.23502823 |
| 20 | microglial cell activation (GO:0001774) | 4.19533217 |
| 21 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 4.08102137 |
| 22 | response to host (GO:0075136) | 4.08102137 |
| 23 | response to host defenses (GO:0052200) | 4.08102137 |
| 24 | positive regulation of heat generation (GO:0031652) | 3.89931675 |
| 25 | respiratory burst (GO:0045730) | 3.89890992 |
| 26 | positive regulation of antigen processing and presentation (GO:0002579) | 3.86032020 |
| 27 | regulation of mononuclear cell migration (GO:0071675) | 3.79727076 |
| 28 | regulation of chronic inflammatory response (GO:0002676) | 3.76434650 |
| 29 | type I interferon signaling pathway (GO:0060337) | 3.75544544 |
| 30 | cellular response to type I interferon (GO:0071357) | 3.75544544 |
| 31 | response to type I interferon (GO:0034340) | 3.71648174 |
| 32 | positive regulation of interferon-beta production (GO:0032728) | 3.71110194 |
| 33 | granulocyte activation (GO:0036230) | 3.61121958 |
| 34 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.58709673 |
| 35 | macrophage activation (GO:0042116) | 3.56522796 |
| 36 | cellular response to exogenous dsRNA (GO:0071360) | 3.56127839 |
| 37 | response to protozoan (GO:0001562) | 3.54864232 |
| 38 | positive regulation of defense response to virus by host (GO:0002230) | 3.54050835 |
| 39 | myeloid cell activation involved in immune response (GO:0002275) | 3.50008725 |
| 40 | neutrophil activation (GO:0042119) | 3.48167198 |
| 41 | response to interferon-alpha (GO:0035455) | 3.47947384 |
| 42 | regulation of cholesterol storage (GO:0010885) | 3.47105085 |
| 43 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.44737427 |
| 44 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 3.44296441 |
| 45 | regulation of cytokine secretion involved in immune response (GO:0002739) | 3.40524821 |
| 46 | B cell mediated immunity (GO:0019724) | 3.38411865 |
| 47 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 3.34394646 |
| 48 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.34046892 |
| 49 | regulation of fever generation (GO:0031620) | 3.32845266 |
| 50 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.32652145 |
| 51 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.32003099 |
| 52 | pinocytosis (GO:0006907) | 3.29056306 |
| 53 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.27810394 |
| 54 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.27810394 |
| 55 | regulation of antigen processing and presentation (GO:0002577) | 3.27620105 |
| 56 | regulation of chemokine biosynthetic process (GO:0045073) | 3.24873340 |
| 57 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.24867648 |
| 58 | natural killer cell mediated immunity (GO:0002228) | 3.24843296 |
| 59 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.24843296 |
| 60 | regulation of vitamin metabolic process (GO:0030656) | 3.24568603 |
| 61 | regulation of interleukin-12 production (GO:0032655) | 3.23054531 |
| 62 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.23029543 |
| 63 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.22122291 |
| 64 | response to muramyl dipeptide (GO:0032495) | 3.21955142 |
| 65 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 3.18943927 |
| 66 | indole-containing compound catabolic process (GO:0042436) | 3.17901560 |
| 67 | indolalkylamine catabolic process (GO:0046218) | 3.17901560 |
| 68 | tryptophan catabolic process (GO:0006569) | 3.17901560 |
| 69 | positive regulation of mast cell activation (GO:0033005) | 3.17781863 |
| 70 | regulation of gamma-delta T cell activation (GO:0046643) | 3.17457633 |
| 71 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 3.16081647 |
| 72 | detection of molecule of bacterial origin (GO:0032490) | 3.14568563 |
| 73 | T-helper 1 type immune response (GO:0042088) | 3.13486851 |
| 74 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.13444206 |
| 75 | positive regulation of type 2 immune response (GO:0002830) | 3.09908023 |
| 76 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.08242004 |
| 77 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 3.07347775 |
| 78 | regulation of growth of symbiont in host (GO:0044126) | 3.07347775 |
| 79 | negative regulation of growth of symbiont in host (GO:0044130) | 3.07347775 |
| 80 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 3.07347775 |
| 81 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.06961323 |
| 82 | negative regulation of cell killing (GO:0031342) | 3.06961323 |
| 83 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.05401593 |
| 84 | lymphocyte chemotaxis (GO:0048247) | 3.04798053 |
| 85 | eosinophil chemotaxis (GO:0048245) | 3.03040366 |
| 86 | regulation of heat generation (GO:0031650) | 3.02764427 |
| 87 | low-density lipoprotein particle clearance (GO:0034383) | 3.02413208 |
| 88 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.00781277 |
| 89 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.99881897 |
| 90 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.98522166 |
| 91 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.98291031 |
| 92 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.95856768 |
| 93 | regulation of mast cell degranulation (GO:0043304) | 2.94922566 |
| 94 | NIK/NF-kappaB signaling (GO:0038061) | 2.94505479 |
| 95 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 2.92810782 |
| 96 | germinal center formation (GO:0002467) | 2.92624678 |
| 97 | interferon-gamma production (GO:0032609) | 2.92383948 |
| 98 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.92321521 |
| 99 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.92176001 |
| 100 | negative regulation of T cell mediated immunity (GO:0002710) | 2.90652464 |
| 101 | superoxide anion generation (GO:0042554) | 2.90128908 |
| 102 | I-kappaB phosphorylation (GO:0007252) | 2.89274709 |
| 103 | myeloid dendritic cell activation (GO:0001773) | 2.88197392 |
| 104 | negative regulation of interleukin-17 production (GO:0032700) | 2.87937475 |
| 105 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.87392247 |
| 106 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.87042867 |
| 107 | positive regulation of mast cell degranulation (GO:0043306) | 2.87042867 |
| 108 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 2.86528260 |
| 109 | cellular response to interferon-alpha (GO:0035457) | 2.86146272 |
| 110 | monocyte chemotaxis (GO:0002548) | 2.85203815 |
| 111 | regulation of T-helper cell differentiation (GO:0045622) | 2.84759110 |
| 112 | kynurenine metabolic process (GO:0070189) | 2.84692467 |
| 113 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.84490054 |
| 114 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.81014251 |
| 115 | regulation of mast cell activation (GO:0033003) | 2.79853666 |
| 116 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.79499723 |
| 117 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 2.78150828 |
| 118 | cellular extravasation (GO:0045123) | 2.78118472 |
| 119 | myeloid dendritic cell differentiation (GO:0043011) | 2.77914243 |
| 120 | positive regulation of T-helper cell differentiation (GO:0045624) | 2.77743504 |
| 121 | regulation of hypersensitivity (GO:0002883) | 2.77356742 |
| 122 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.76802767 |
| 123 | positive regulation of leukocyte degranulation (GO:0043302) | 2.76776217 |
| 124 | cellular response to ethanol (GO:0071361) | 2.76327562 |
| 125 | regulation of interferon-beta production (GO:0032648) | 2.76283564 |
| 126 | myeloid leukocyte activation (GO:0002274) | 2.75831077 |
| 127 | regulation of podosome assembly (GO:0071801) | 2.75178745 |
| 128 | tryptophan metabolic process (GO:0006568) | 2.74983184 |
| 129 | dendritic cell differentiation (GO:0097028) | 2.74176653 |
| 130 | response to interferon-beta (GO:0035456) | 2.73398365 |
| 131 | defense response to protozoan (GO:0042832) | 2.73155338 |
| 132 | negative regulation of production of molecular mediator of immune response (GO:0002701) | 2.72289366 |
| 133 | negative regulation of viral genome replication (GO:0045071) | 2.72206621 |
| 134 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.71915302 |
| 135 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.71212879 |
| 136 | regulation of defense response to virus by host (GO:0050691) | 2.71212360 |
| 137 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.71180457 |
| 138 | positive regulation of acute inflammatory response (GO:0002675) | 2.70415243 |
| 139 | cellular response to virus (GO:0098586) | 2.68859001 |
| 140 | lymphocyte mediated immunity (GO:0002449) | 2.67395947 |
| 141 | positive regulation of lymphocyte migration (GO:2000403) | 2.67244720 |
| 142 | negative regulation of lipid storage (GO:0010888) | 2.66808607 |
| 143 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.65492675 |
| 144 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.64742366 |
| 145 | positive regulation of interleukin-12 production (GO:0032735) | 2.64385240 |
| 146 | reactive oxygen species biosynthetic process (GO:1903409) | 2.64170157 |
| 147 | negative regulation of mast cell activation (GO:0033004) | 2.63888732 |
| 148 | response to thyroid hormone (GO:0097066) | 2.63565905 |
| 149 | cellular response to interferon-beta (GO:0035458) | 2.63424675 |
| 150 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobuli | 2.63382582 |
| 151 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.62729239 |
| 152 | eosinophil migration (GO:0072677) | 2.62518026 |
| 153 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.61447163 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 6.93452334 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.67725125 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.94358468 |
| 4 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.48699263 |
| 5 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 4.10786178 |
| 6 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.09071577 |
| 7 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.74616331 |
| 8 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.65079065 |
| 9 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.55086502 |
| 10 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.83508544 |
| 11 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.79599020 |
| 12 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.78087712 |
| 13 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.71060273 |
| 14 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.53132691 |
| 15 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.40010260 |
| 16 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.25179016 |
| 17 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.24575959 |
| 18 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.21888227 |
| 19 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.10783536 |
| 20 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.06267357 |
| 21 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 2.05771482 |
| 22 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.02293715 |
| 23 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.00128746 |
| 24 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.91815042 |
| 25 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.84356673 |
| 26 | SPI1_23127762_ChIP-Seq_K562_Human | 1.73669887 |
| 27 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.73135646 |
| 28 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.70874915 |
| 29 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.69463856 |
| 30 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.68634568 |
| 31 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.67300940 |
| 32 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.62677674 |
| 33 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.62118371 |
| 34 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.61904907 |
| 35 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.52986207 |
| 36 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.52793859 |
| 37 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.51408087 |
| 38 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.49740870 |
| 39 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.47578450 |
| 40 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.46189198 |
| 41 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.42184016 |
| 42 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.41364990 |
| 43 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.39287911 |
| 44 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.37959486 |
| 45 | MYB_26560356_Chip-Seq_TH2_Human | 1.35762127 |
| 46 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.34607936 |
| 47 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.34317747 |
| 48 | MAF_26560356_Chip-Seq_TH1_Human | 1.34084353 |
| 49 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.33213854 |
| 50 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.32400277 |
| 51 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.31695866 |
| 52 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.31579204 |
| 53 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.30081290 |
| 54 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.29949715 |
| 55 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.26435300 |
| 56 | GATA1_22025678_ChIP-Seq_K562_Human | 1.25719017 |
| 57 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.24463499 |
| 58 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.23832469 |
| 59 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.20039746 |
| 60 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.20016067 |
| 61 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.17213094 |
| 62 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.15837097 |
| 63 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.14864300 |
| 64 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.14129968 |
| 65 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.13989217 |
| 66 | MYB_26560356_Chip-Seq_TH1_Human | 1.13679616 |
| 67 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.13343902 |
| 68 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.13241061 |
| 69 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.11115422 |
| 70 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.10980304 |
| 71 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.08622071 |
| 72 | GATA3_26560356_Chip-Seq_TH2_Human | 1.07064097 |
| 73 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.06567792 |
| 74 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.06130146 |
| 75 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.05165764 |
| 76 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.03490105 |
| 77 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.02277121 |
| 78 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.99327184 |
| 79 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.98951022 |
| 80 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.98749565 |
| 81 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.98674485 |
| 82 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.98137485 |
| 83 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.97600456 |
| 84 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.97297396 |
| 85 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.92112813 |
| 86 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.91960207 |
| 87 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.90319588 |
| 88 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.90316567 |
| 89 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.90311024 |
| 90 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.89926105 |
| 91 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.88817086 |
| 92 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.87455372 |
| 93 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.85792223 |
| 94 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.84232162 |
| 95 | UTX_26944678_Chip-Seq_JUKART_Human | 0.83801907 |
| 96 | * EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.83660589 |
| 97 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.83505660 |
| 98 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.82802917 |
| 99 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.82710154 |
| 100 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.81287872 |
| 101 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.80503497 |
| 102 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.80026827 |
| 103 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.79415854 |
| 104 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.79245589 |
| 105 | CJUN_26792858_Chip-Seq_BT549_Human | 0.77340427 |
| 106 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.76953830 |
| 107 | GATA2_19941826_ChIP-Seq_K562_Human | 0.76928073 |
| 108 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.76592140 |
| 109 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.75153749 |
| 110 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.75153749 |
| 111 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.73988540 |
| 112 | GATA1_19941826_ChIP-Seq_K562_Human | 0.73796517 |
| 113 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.72970817 |
| 114 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.72940486 |
| 115 | MAF_26560356_Chip-Seq_TH2_Human | 0.72365060 |
| 116 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.72070033 |
| 117 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.71798163 |
| 118 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.71713028 |
| 119 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.71401550 |
| 120 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.71365919 |
| 121 | * GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.70491529 |
| 122 | P300_27268052_Chip-Seq_Bcells_Human | 0.68529908 |
| 123 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.67408413 |
| 124 | GATA3_26560356_Chip-Seq_TH1_Human | 0.66775120 |
| 125 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.66652906 |
| 126 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.65417993 |
| 127 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.65410334 |
| 128 | * GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.64143673 |
| 129 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.61789126 |
| 130 | TCF12/HEB_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.61474325 |
| 131 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.61448598 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005058_abnormal_lysosome_morphology | 4.34122967 |
| 2 | MP0001835_abnormal_antigen_presentation | 4.14757335 |
| 3 | MP0003436_decreased_susceptibility_to | 3.57917167 |
| 4 | MP0006082_CNS_inflammation | 3.36001505 |
| 5 | MP0003724_increased_susceptibility_to | 3.01409178 |
| 6 | MP0002148_abnormal_hypersensitivity_rea | 2.99872467 |
| 7 | MP0003303_peritoneal_inflammation | 2.97103328 |
| 8 | MP0009785_altered_susceptibility_to | 2.94928483 |
| 9 | MP0002419_abnormal_innate_immunity | 2.92949663 |
| 10 | MP0005000_abnormal_immune_tolerance | 2.76635088 |
| 11 | MP0003172_abnormal_lysosome_physiology | 2.75415864 |
| 12 | MP0009840_abnormal_foam_cell | 2.74885737 |
| 13 | MP0001790_abnormal_immune_system | 2.59413370 |
| 14 | MP0005387_immune_system_phenotype | 2.59413370 |
| 15 | MP0005025_abnormal_response_to | 2.58269526 |
| 16 | MP0000685_abnormal_immune_system | 2.30404157 |
| 17 | MP0002452_abnormal_antigen_presenting | 2.30156446 |
| 18 | MP0003191_abnormal_cellular_cholesterol | 2.28421026 |
| 19 | MP0004510_myositis | 2.22909578 |
| 20 | MP0001800_abnormal_humoral_immune | 2.14379523 |
| 21 | MP0001533_abnormal_skeleton_physiology | 2.13109940 |
| 22 | MP0002723_abnormal_immune_serum | 2.11823649 |
| 23 | MP0005671_abnormal_response_to | 1.99478249 |
| 24 | MP0005464_abnormal_platelet_physiology | 1.91541701 |
| 25 | MP0000569_abnormal_digit_pigmentation | 1.89851051 |
| 26 | MP0003300_gastrointestinal_ulcer | 1.89560879 |
| 27 | MP0001819_abnormal_immune_cell | 1.86451035 |
| 28 | MP0002420_abnormal_adaptive_immunity | 1.82905244 |
| 29 | MP0001845_abnormal_inflammatory_respons | 1.72884328 |
| 30 | MP0009764_decreased_sensitivity_to | 1.72635014 |
| 31 | MP0000343_altered_response_to | 1.72218025 |
| 32 | MP0008469_abnormal_protein_level | 1.71101559 |
| 33 | MP0004947_skin_inflammation | 1.69231936 |
| 34 | MP0002405_respiratory_system_inflammati | 1.67683655 |
| 35 | MP0003448_altered_tumor_morphology | 1.66965461 |
| 36 | MP0006054_spinal_hemorrhage | 1.63336313 |
| 37 | MP0005310_abnormal_salivary_gland | 1.61994399 |
| 38 | MP0000604_amyloidosis | 1.61151445 |
| 39 | MP0003646_muscle_fatigue | 1.54460849 |
| 40 | MP0002998_abnormal_bone_remodeling | 1.53518637 |
| 41 | MP0003690_abnormal_glial_cell | 1.52835498 |
| 42 | MP0008004_abnormal_stomach_pH | 1.45842247 |
| 43 | MP0005360_urolithiasis | 1.45462396 |
| 44 | MP0010155_abnormal_intestine_physiology | 1.45334621 |
| 45 | MP0003075_altered_response_to | 1.44398871 |
| 46 | MP0001853_heart_inflammation | 1.42552811 |
| 47 | MP0008438_abnormal_cutaneous_collagen | 1.39221711 |
| 48 | MP0002166_altered_tumor_susceptibility | 1.34366130 |
| 49 | MP0009333_abnormal_splenocyte_physiolog | 1.29724286 |
| 50 | MP0002138_abnormal_hepatobiliary_system | 1.29278569 |
| 51 | MP0000716_abnormal_immune_system | 1.29036805 |
| 52 | MP0005451_abnormal_body_composition | 1.28717550 |
| 53 | MP0009278_abnormal_bone_marrow | 1.25387656 |
| 54 | MP0002006_tumorigenesis | 1.23295814 |
| 55 | MP0000858_altered_metastatic_potential | 1.20804712 |
| 56 | MP0005257_abnormal_intraocular_pressure | 1.19901606 |
| 57 | MP0002332_abnormal_exercise_endurance | 1.18421991 |
| 58 | MP0003195_calcinosis | 1.17974795 |
| 59 | MP0001958_emphysema | 1.17001060 |
| 60 | MP0010307_abnormal_tumor_latency | 1.15294788 |
| 61 | MP0000689_abnormal_spleen_morphology | 1.14074763 |
| 62 | MP0005167_abnormal_blood-brain_barrier | 1.11527676 |
| 63 | MP0003806_abnormal_nucleotide_metabolis | 1.11284347 |
| 64 | MP0003186_abnormal_redox_activity | 1.11159528 |
| 65 | MP0005166_decreased_susceptibility_to | 1.10499918 |
| 66 | MP0002136_abnormal_kidney_physiology | 1.10368311 |
| 67 | MP0002398_abnormal_bone_marrow | 1.09825316 |
| 68 | MP0003566_abnormal_cell_adhesion | 1.06833700 |
| 69 | MP0003183_abnormal_peptide_metabolism | 1.05038028 |
| 70 | MP0004019_abnormal_vitamin_homeostasis | 1.04738154 |
| 71 | MP0009763_increased_sensitivity_to | 1.04192768 |
| 72 | MP0002429_abnormal_blood_cell | 1.04140736 |
| 73 | MP0003705_abnormal_hypodermis_morpholog | 1.04063634 |
| 74 | MP0003763_abnormal_thymus_physiology | 1.03793229 |
| 75 | MP0005174_abnormal_tail_pigmentation | 1.03295726 |
| 76 | MP0004782_abnormal_surfactant_physiolog | 1.01757755 |
| 77 | MP0001851_eye_inflammation | 1.00983375 |
| 78 | MP0001663_abnormal_digestive_system | 1.00532523 |
| 79 | MP0009643_abnormal_urine_homeostasis | 0.99593130 |
| 80 | MP0005390_skeleton_phenotype | 0.98591613 |
| 81 | MP0002277_abnormal_respiratory_mucosa | 0.97269697 |
| 82 | MP0002254_reproductive_system_inflammat | 0.96821141 |
| 83 | MP0002722_abnormal_immune_system | 0.95604786 |
| 84 | MP0002933_joint_inflammation | 0.94187873 |
| 85 | MP0005164_abnormal_response_to | 0.88256627 |
| 86 | MP0004043_abnormal_pH_regulation | 0.86802338 |
| 87 | MP0001545_abnormal_hematopoietic_system | 0.86197729 |
| 88 | MP0005397_hematopoietic_system_phenotyp | 0.86197729 |
| 89 | MP0000249_abnormal_blood_vessel | 0.86126832 |
| 90 | MP0001501_abnormal_sleep_pattern | 0.85463422 |
| 91 | MP0000609_abnormal_liver_physiology | 0.84716387 |
| 92 | MP0003828_pulmonary_edema | 0.80917273 |
| 93 | MP0005076_abnormal_cell_differentiation | 0.79292157 |
| 94 | MP0009765_abnormal_xenobiotic_induced | 0.78332515 |
| 95 | MP0000465_gastrointestinal_hemorrhage | 0.77797026 |
| 96 | MP0005319_abnormal_enzyme/_coenzyme | 0.77784686 |
| 97 | MP0000371_diluted_coat_color | 0.77263807 |
| 98 | MP0001756_abnormal_urination | 0.76947541 |
| 99 | MP0005647_abnormal_sex_gland | 0.75004131 |
| 100 | MP0002693_abnormal_pancreas_physiology | 0.74535765 |
| 101 | MP0003795_abnormal_bone_structure | 0.73890859 |
| 102 | MP0010329_abnormal_lipoprotein_level | 0.72497002 |
| 103 | MP0001542_abnormal_bone_strength | 0.71347713 |
| 104 | MP0004883_abnormal_blood_vessel | 0.71075839 |
| 105 | MP0001873_stomach_inflammation | 0.70457598 |
| 106 | MP0008875_abnormal_xenobiotic_pharmacok | 0.70413733 |
| 107 | MP0002139_abnormal_hepatobiliary_system | 0.70082666 |
| 108 | MP0005083_abnormal_biliary_tract | 0.69703992 |
| 109 | MP0005670_abnormal_white_adipose | 0.69366181 |
| 110 | MP0005332_abnormal_amino_acid | 0.69083970 |
| 111 | MP0005084_abnormal_gallbladder_morpholo | 0.67559589 |
| 112 | MP0005365_abnormal_bile_salt | 0.66966781 |
| 113 | MP0003091_abnormal_cell_migration | 0.65144402 |
| 114 | MP0003453_abnormal_keratinocyte_physiol | 0.65029736 |
| 115 | MP0000015_abnormal_ear_pigmentation | 0.63772994 |
| 116 | MP0005165_increased_susceptibility_to | 0.62234540 |
| 117 | MP0003045_fibrosis | 0.62125388 |
| 118 | MP0003656_abnormal_erythrocyte_physiolo | 0.62115202 |
| 119 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.62057699 |
| 120 | MP0001986_abnormal_taste_sensitivity | 0.60634010 |
| 121 | MP0005535_abnormal_body_temperature | 0.56233192 |
| 122 | MP0005410_abnormal_fertilization | 0.56030947 |
| 123 | MP0000920_abnormal_myelination | 0.55477030 |
| 124 | MP0003866_abnormal_defecation | 0.55157050 |
| 125 | MP0001764_abnormal_homeostasis | 0.55059762 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 6.20823871 |
| 2 | Systemic lupus erythematosus (HP:0002725) | 6.18071190 |
| 3 | Vacuolated lymphocytes (HP:0001922) | 5.88660225 |
| 4 | Increased cerebral lipofuscin (HP:0011813) | 5.55622872 |
| 5 | Recurrent bacterial skin infections (HP:0005406) | 5.54029245 |
| 6 | Eczematoid dermatitis (HP:0000976) | 5.50695862 |
| 7 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.94546371 |
| 8 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 4.88383723 |
| 9 | Abnormality of macrophages (HP:0004311) | 4.85988850 |
| 10 | Autoimmune thrombocytopenia (HP:0001973) | 4.32865457 |
| 11 | Glomerulonephritis (HP:0000099) | 4.30905542 |
| 12 | Dysostosis multiplex (HP:0000943) | 4.29694063 |
| 13 | Axonal loss (HP:0003447) | 3.95788933 |
| 14 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.86755366 |
| 15 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.86755366 |
| 16 | Abnormality of glycolipid metabolism (HP:0010969) | 3.86755366 |
| 17 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.76220182 |
| 18 | Mucopolysacchariduria (HP:0008155) | 3.76220182 |
| 19 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.61034173 |
| 20 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.61034173 |
| 21 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.61034173 |
| 22 | Gingivitis (HP:0000230) | 3.57556240 |
| 23 | Disinhibition (HP:0000734) | 3.45054127 |
| 24 | Keratoconjunctivitis (HP:0001096) | 3.40278961 |
| 25 | Keratoconjunctivitis sicca (HP:0001097) | 3.38514789 |
| 26 | Mediastinal lymphadenopathy (HP:0100721) | 3.38154573 |
| 27 | Recurrent skin infections (HP:0001581) | 3.36212708 |
| 28 | Myositis (HP:0100614) | 3.32958333 |
| 29 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.26703374 |
| 30 | Loss of speech (HP:0002371) | 3.23307889 |
| 31 | Orchitis (HP:0100796) | 3.23111677 |
| 32 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.20426086 |
| 33 | Complement deficiency (HP:0004431) | 3.11119040 |
| 34 | Chronic obstructive pulmonary disease (HP:0006510) | 3.10980706 |
| 35 | Obstructive lung disease (HP:0006536) | 3.10980706 |
| 36 | Abnormality of complement system (HP:0005339) | 3.06240702 |
| 37 | Nephritis (HP:0000123) | 3.03426797 |
| 38 | Myocardial infarction (HP:0001658) | 2.98417967 |
| 39 | Prostate neoplasm (HP:0100787) | 2.96359410 |
| 40 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.95868617 |
| 41 | Recurrent fungal infections (HP:0002841) | 2.89058844 |
| 42 | Basal ganglia calcification (HP:0002135) | 2.85063586 |
| 43 | Stomatitis (HP:0010280) | 2.82310574 |
| 44 | Mutism (HP:0002300) | 2.78236191 |
| 45 | Periodontitis (HP:0000704) | 2.73284461 |
| 46 | Optic neuritis (HP:0100653) | 2.68929135 |
| 47 | Retrobulbar optic neuritis (HP:0100654) | 2.68929135 |
| 48 | Thick nail (HP:0001805) | 2.68306668 |
| 49 | Encephalitis (HP:0002383) | 2.67748644 |
| 50 | Pustule (HP:0200039) | 2.62417273 |
| 51 | Gangrene (HP:0100758) | 2.58893040 |
| 52 | Abnormality of T cell number (HP:0011839) | 2.58709331 |
| 53 | Interstitial pulmonary disease (HP:0006530) | 2.58701339 |
| 54 | T lymphocytopenia (HP:0005403) | 2.58201731 |
| 55 | Pathologic fracture (HP:0002756) | 2.54501060 |
| 56 | Vasculitis (HP:0002633) | 2.53848523 |
| 57 | Urticaria (HP:0001025) | 2.51708330 |
| 58 | Hepatosplenomegaly (HP:0001433) | 2.49425686 |
| 59 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.47706244 |
| 60 | Abnormality of B cell number (HP:0010975) | 2.47640748 |
| 61 | Polyneuropathy (HP:0001271) | 2.46878825 |
| 62 | Nausea (HP:0002018) | 2.45792032 |
| 63 | Recurrent viral infections (HP:0004429) | 2.44251038 |
| 64 | Gastrointestinal infarctions (HP:0005244) | 2.43283813 |
| 65 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.37784202 |
| 66 | Agnosia (HP:0010524) | 2.36753807 |
| 67 | Bone pain (HP:0002653) | 2.35511319 |
| 68 | Abnormality of the pleura (HP:0002103) | 2.34088323 |
| 69 | Tetraparesis (HP:0002273) | 2.33759473 |
| 70 | Spontaneous hematomas (HP:0007420) | 2.32662965 |
| 71 | Hematochezia (HP:0002573) | 2.32149225 |
| 72 | Progressive visual loss (HP:0000529) | 2.26628701 |
| 73 | Autoimmune hemolytic anemia (HP:0001890) | 2.24893057 |
| 74 | Joint hemorrhage (HP:0005261) | 2.22180835 |
| 75 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.21059714 |
| 76 | Osteolytic defects of the hand bones (HP:0009699) | 2.21059714 |
| 77 | Pulmonary embolism (HP:0002204) | 2.20765862 |
| 78 | Cellulitis (HP:0100658) | 2.20035043 |
| 79 | Upper motor neuron abnormality (HP:0002127) | 2.19289357 |
| 80 | Chronic otitis media (HP:0000389) | 2.18326664 |
| 81 | J-shaped sella turcica (HP:0002680) | 2.17849119 |
| 82 | Abnormality of iron homeostasis (HP:0011031) | 2.17745828 |
| 83 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.15609589 |
| 84 | Mesangial abnormality (HP:0001966) | 2.13802536 |
| 85 | Osteomyelitis (HP:0002754) | 2.13548698 |
| 86 | Abnormality of proline metabolism (HP:0010907) | 2.12142814 |
| 87 | Hydroxyprolinuria (HP:0003080) | 2.12142814 |
| 88 | Parakeratosis (HP:0001036) | 2.11433659 |
| 89 | Metaphyseal irregularity (HP:0003025) | 2.10768971 |
| 90 | Peripheral demyelination (HP:0011096) | 2.08991636 |
| 91 | Increased IgM level (HP:0003496) | 2.08926941 |
| 92 | Purpura (HP:0000979) | 2.08010553 |
| 93 | Conjunctival telangiectasia (HP:0000524) | 2.06217973 |
| 94 | Premature loss of primary teeth (HP:0006323) | 2.06037684 |
| 95 | Vertebral compression fractures (HP:0002953) | 2.04580215 |
| 96 | Recurrent cutaneous fungal infections (HP:0011370) | 2.04480493 |
| 97 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.04480493 |
| 98 | Vertigo (HP:0002321) | 2.04082750 |
| 99 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.03411423 |
| 100 | Joint swelling (HP:0001386) | 2.02975729 |
| 101 | Episodic fever (HP:0001954) | 2.02843072 |
| 102 | Abnormality of the pericardium (HP:0001697) | 2.02121570 |
| 103 | B lymphocytopenia (HP:0010976) | 2.02101445 |
| 104 | Pulmonary infiltrates (HP:0002113) | 2.00584189 |
| 105 | Keratitis (HP:0000491) | 2.00050827 |
| 106 | Leukocytosis (HP:0001974) | 1.99994752 |
| 107 | Gingival bleeding (HP:0000225) | 1.98561020 |
| 108 | Eosinophilia (HP:0001880) | 1.97986103 |
| 109 | Esophageal varix (HP:0002040) | 1.97073434 |
| 110 | Asymmetric septal hypertrophy (HP:0001670) | 1.95177464 |
| 111 | Abnormality of T cells (HP:0002843) | 1.94499500 |
| 112 | Albinism (HP:0001022) | 1.93886975 |
| 113 | Recurrent pneumonia (HP:0006532) | 1.93688524 |
| 114 | Abnormality of the endocardium (HP:0004306) | 1.91092093 |
| 115 | Petechiae (HP:0000967) | 1.90164071 |
| 116 | Arterial thrombosis (HP:0004420) | 1.90062216 |
| 117 | Anorexia (HP:0002039) | 1.88962633 |
| 118 | Abnormality of eosinophils (HP:0001879) | 1.86373924 |
| 119 | Acne (HP:0001061) | 1.85966871 |
| 120 | Abnormality of the lumbar spine (HP:0100712) | 1.85681532 |
| 121 | Alveolar cell carcinoma (HP:0006519) | 1.85282864 |
| 122 | Amyloidosis (HP:0011034) | 1.84776829 |
| 123 | Hypergammaglobulinemia (HP:0010702) | 1.83956264 |
| 124 | Abnormality of the nasal mucosa (HP:0000433) | 1.83196054 |
| 125 | Granulocytopenia (HP:0001913) | 1.79267676 |
| 126 | Inappropriate behavior (HP:0000719) | 1.78877826 |
| 127 | Increased serum ferritin (HP:0003281) | 1.78778301 |
| 128 | Arthralgia (HP:0002829) | 1.77779043 |
| 129 | Abolished electroretinogram (ERG) (HP:0000550) | 1.77202343 |
| 130 | Glomerulopathy (HP:0100820) | 1.77044146 |
| 131 | Nasal polyposis (HP:0100582) | 1.76657101 |
| 132 | Stomach cancer (HP:0012126) | 1.76607729 |
| 133 | Colitis (HP:0002583) | 1.76370588 |
| 134 | Abnormality of the prostate (HP:0008775) | 1.75618969 |
| 135 | Meningitis (HP:0001287) | 1.75281398 |
| 136 | Thoracic kyphosis (HP:0002942) | 1.74577482 |
| 137 | Hypercholesterolemia (HP:0003124) | 1.73127581 |
| 138 | Diminished motivation (HP:0000745) | 1.72851059 |
| 139 | Hemoptysis (HP:0002105) | 1.72019560 |
| 140 | Neoplasm of head and neck (HP:0012288) | 1.71375981 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BLK | 3.85975045 |
| 2 | TYK2 | 3.71457965 |
| 3 | MAP3K14 | 3.57152702 |
| 4 | TBK1 | 3.50335076 |
| 5 | ERN1 | 3.27418809 |
| 6 | IRAK3 | 3.21463038 |
| 7 | KIT | 3.06773218 |
| 8 | RIPK4 | 3.00447724 |
| 9 | IRAK4 | 2.86350778 |
| 10 | IKBKE | 2.66816438 |
| 11 | MAP4K1 | 2.46808806 |
| 12 | FRK | 2.38849168 |
| 13 | JAK1 | 2.31592480 |
| 14 | PBK | 2.19941853 |
| 15 | TGFBR2 | 2.12949625 |
| 16 | IKBKB | 2.08783236 |
| 17 | JAK3 | 2.08513589 |
| 18 | ACVR1B | 1.80547983 |
| 19 | PIM2 | 1.79760135 |
| 20 | EPHB1 | 1.79106178 |
| 21 | KDR | 1.73607824 |
| 22 | TXK | 1.63084580 |
| 23 | NEK9 | 1.60613231 |
| 24 | CSK | 1.60374179 |
| 25 | FGFR4 | 1.58678562 |
| 26 | ZAP70 | 1.56056698 |
| 27 | DDR2 | 1.55233905 |
| 28 | TAOK3 | 1.46849840 |
| 29 | CDC42BPA | 1.41583664 |
| 30 | MST1R | 1.40307870 |
| 31 | NME2 | 1.36937132 |
| 32 | HCK | 1.29669292 |
| 33 | SYK | 1.26809660 |
| 34 | TLK1 | 1.26639160 |
| 35 | BMX | 1.26360182 |
| 36 | MAP4K2 | 1.25240063 |
| 37 | MAP3K13 | 1.23575509 |
| 38 | CSF1R | 1.22606273 |
| 39 | CHUK | 1.22502098 |
| 40 | TAOK2 | 1.19779221 |
| 41 | JAK2 | 1.18768292 |
| 42 | TAOK1 | 1.17489501 |
| 43 | CAMK1D | 1.17371928 |
| 44 | LYN | 1.13454337 |
| 45 | ABL2 | 1.12967297 |
| 46 | RIPK1 | 1.10574995 |
| 47 | LCK | 1.02125155 |
| 48 | FGR | 0.99405837 |
| 49 | MAP2K3 | 0.98438121 |
| 50 | FES | 0.97306053 |
| 51 | STK10 | 0.95869703 |
| 52 | MATK | 0.93872937 |
| 53 | FGFR3 | 0.93538269 |
| 54 | BTK | 0.92165704 |
| 55 | MAP2K6 | 0.91059070 |
| 56 | GRK7 | 0.90728193 |
| 57 | TNK2 | 0.90068034 |
| 58 | BMPR2 | 0.89757184 |
| 59 | RPS6KA4 | 0.89198175 |
| 60 | MST4 | 0.88645185 |
| 61 | PIM1 | 0.85728491 |
| 62 | EPHA3 | 0.84175491 |
| 63 | PTK6 | 0.83258917 |
| 64 | MAP3K3 | 0.82734682 |
| 65 | TEC | 0.81494169 |
| 66 | PRKCD | 0.75020463 |
| 67 | EGFR | 0.74727405 |
| 68 | TRIB3 | 0.71995189 |
| 69 | DAPK2 | 0.71131458 |
| 70 | GRK1 | 0.69680419 |
| 71 | IRAK1 | 0.67871104 |
| 72 | ABL1 | 0.67074515 |
| 73 | MARK3 | 0.65977461 |
| 74 | PRKCQ | 0.65744232 |
| 75 | TTN | 0.65485294 |
| 76 | WNK4 | 0.63507061 |
| 77 | STK3 | 0.61268681 |
| 78 | LRRK2 | 0.60292312 |
| 79 | CAMK1G | 0.58690097 |
| 80 | MAP3K5 | 0.56137073 |
| 81 | PRKAA2 | 0.56045436 |
| 82 | PDK1 | 0.55134230 |
| 83 | MAP3K11 | 0.54326523 |
| 84 | TRPM7 | 0.53138984 |
| 85 | STK4 | 0.51053257 |
| 86 | MOS | 0.49909882 |
| 87 | PKN1 | 0.49608347 |
| 88 | SIK2 | 0.48548034 |
| 89 | CDK6 | 0.48511162 |
| 90 | SCYL2 | 0.47565473 |
| 91 | EIF2AK2 | 0.47470329 |
| 92 | PAK4 | 0.45549554 |
| 93 | HIPK2 | 0.45057923 |
| 94 | INSRR | 0.44881942 |
| 95 | ADRBK1 | 0.43595716 |
| 96 | ITK | 0.43125223 |
| 97 | CLK1 | 0.42843774 |
| 98 | ARAF | 0.40962966 |
| 99 | TIE1 | 0.40832547 |
| 100 | GRK6 | 0.40146185 |
| 101 | TGFBR1 | 0.39495553 |
| 102 | TESK1 | 0.39416242 |
| 103 | IGF1R | 0.38969349 |
| 104 | PRKG2 | 0.38380732 |
| 105 | MAP3K1 | 0.37180189 |
| 106 | OXSR1 | 0.36744249 |
| 107 | IRAK2 | 0.35003239 |
| 108 | CAMKK2 | 0.34899876 |
| 109 | MAPKAPK3 | 0.33820461 |
| 110 | MAPKAPK2 | 0.33104576 |
| 111 | FYN | 0.32715906 |
| 112 | PIK3CG | 0.32052621 |
| 113 | ADRBK2 | 0.31265349 |
| 114 | GSK3A | 0.31254486 |
| 115 | PDPK1 | 0.29988372 |
| 116 | MAP2K2 | 0.29820487 |
| 117 | MAPK4 | 0.29187978 |
| 118 | STK24 | 0.28742911 |
| 119 | PRKD2 | 0.28718403 |
| 120 | INSR | 0.27710019 |
| 121 | NUAK1 | 0.27648514 |
| 122 | WNK3 | 0.27551404 |
| 123 | MAPK7 | 0.26159071 |
| 124 | YES1 | 0.25965731 |
| 125 | ZAK | 0.25708649 |
| 126 | ERBB3 | 0.25700418 |
| 127 | BCKDK | 0.25478821 |
| 128 | PKN2 | 0.25426335 |
| 129 | BMPR1B | 0.24669307 |
| 130 | MAPK11 | 0.24580221 |
| 131 | CDK12 | 0.23954335 |
| 132 | PTK2B | 0.23859821 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 4.06811827 |
| 2 | Lysosome_Homo sapiens_hsa04142 | 3.22061908 |
| 3 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 3.05584290 |
| 4 | Leishmaniasis_Homo sapiens_hsa05140 | 3.03847934 |
| 5 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.73953676 |
| 6 | Other glycan degradation_Homo sapiens_hsa00511 | 2.66897088 |
| 7 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.34733591 |
| 8 | Pertussis_Homo sapiens_hsa05133 | 2.32639979 |
| 9 | Malaria_Homo sapiens_hsa05144 | 2.19315924 |
| 10 | Tuberculosis_Homo sapiens_hsa05152 | 2.17410569 |
| 11 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.08786681 |
| 12 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.04634401 |
| 13 | Legionellosis_Homo sapiens_hsa05134 | 1.99276062 |
| 14 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.94533406 |
| 15 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.91295342 |
| 16 | Phagosome_Homo sapiens_hsa04145 | 1.86075417 |
| 17 | Measles_Homo sapiens_hsa05162 | 1.85095972 |
| 18 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.84522035 |
| 19 | Allograft rejection_Homo sapiens_hsa05330 | 1.81905660 |
| 20 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.68168485 |
| 21 | Influenza A_Homo sapiens_hsa05164 | 1.67204329 |
| 22 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.63305855 |
| 23 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.61433852 |
| 24 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.61184821 |
| 25 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.58814839 |
| 26 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.50351357 |
| 27 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.50188715 |
| 28 | Asthma_Homo sapiens_hsa05310 | 1.50097150 |
| 29 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.44757069 |
| 30 | Salmonella infection_Homo sapiens_hsa05132 | 1.43691310 |
| 31 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.39417880 |
| 32 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.35097076 |
| 33 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.34950297 |
| 34 | Apoptosis_Homo sapiens_hsa04210 | 1.31109983 |
| 35 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.26591533 |
| 36 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.21677520 |
| 37 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.19920445 |
| 38 | Shigellosis_Homo sapiens_hsa05131 | 1.19912360 |
| 39 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.19382551 |
| 40 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.13753817 |
| 41 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.12846944 |
| 42 | Hepatitis C_Homo sapiens_hsa05160 | 1.11648091 |
| 43 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.11596422 |
| 44 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.10961674 |
| 45 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.09088146 |
| 46 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.08589888 |
| 47 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.08321550 |
| 48 | Mineral absorption_Homo sapiens_hsa04978 | 1.04414098 |
| 49 | Viral myocarditis_Homo sapiens_hsa05416 | 0.91990938 |
| 50 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.89407574 |
| 51 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.88959659 |
| 52 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.84843496 |
| 53 | Hepatitis B_Homo sapiens_hsa05161 | 0.83871396 |
| 54 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.83844859 |
| 55 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.83670816 |
| 56 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.83614750 |
| 57 | Amoebiasis_Homo sapiens_hsa05146 | 0.81297714 |
| 58 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.78367493 |
| 59 | Prion diseases_Homo sapiens_hsa05020 | 0.76823357 |
| 60 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.74705288 |
| 61 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.74528199 |
| 62 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.73438465 |
| 63 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.73436579 |
| 64 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.70027731 |
| 65 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.68204947 |
| 66 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.67894809 |
| 67 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.67654922 |
| 68 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.66989532 |
| 69 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.66976058 |
| 70 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.66789779 |
| 71 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.63978517 |
| 72 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.63834805 |
| 73 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.62139107 |
| 74 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.59850935 |
| 75 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.51127516 |
| 76 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.49817668 |
| 77 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.49002568 |
| 78 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.48630526 |
| 79 | Histidine metabolism_Homo sapiens_hsa00340 | 0.47683766 |
| 80 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.47539588 |
| 81 | Peroxisome_Homo sapiens_hsa04146 | 0.46080027 |
| 82 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.45599172 |
| 83 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.44822457 |
| 84 | ABC transporters_Homo sapiens_hsa02010 | 0.42975553 |
| 85 | Galactose metabolism_Homo sapiens_hsa00052 | 0.42141493 |
| 86 | Platelet activation_Homo sapiens_hsa04611 | 0.41598874 |
| 87 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.40765846 |
| 88 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.40073093 |
| 89 | Endocytosis_Homo sapiens_hsa04144 | 0.39726896 |
| 90 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.38826782 |
| 91 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.38323926 |
| 92 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.38296639 |
| 93 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.36458905 |
| 94 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.36396078 |
| 95 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.36278936 |
| 96 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.35926605 |
| 97 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.35428068 |
| 98 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.35240507 |
| 99 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.34821360 |
| 100 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.30961205 |
| 101 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.30717793 |
| 102 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.29749665 |
| 103 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.29650369 |
| 104 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.27052941 |
| 105 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.25733136 |
| 106 | Bladder cancer_Homo sapiens_hsa05219 | 0.25664426 |
| 107 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.24393831 |
| 108 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.24261567 |
| 109 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.23288931 |
| 110 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.23039023 |
| 111 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.21888742 |
| 112 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.21560541 |
| 113 | Insulin resistance_Homo sapiens_hsa04931 | 0.21555607 |
| 114 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.21397884 |
| 115 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.20497055 |
| 116 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.19693527 |
| 117 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.19265111 |
| 118 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.18164856 |
| 119 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.17918412 |
| 120 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.14591513 |
| 121 | HTLV-I infection_Homo sapiens_hsa05166 | 0.14028416 |
| 122 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.13801375 |
| 123 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.13794140 |
| 124 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.11007963 |
| 125 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.10262895 |

